Lido Advisors
HQL

Lido Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Lido Advisors’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-26,500
Closed -$397K – 632
2020
Q1 		$397K Hold
26,500
– – 0.02% 373
2019
Q4 		$462K Buy
26,500
+6,500
+33% +$107K 0.02% 404
2019
Q3 		$302K Buy
+20,000
New +$320K 0.02% 447

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MC
Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Lido Advisors's HQL Position: Q2 2020 in Review

Lido Advisors sold out of abrdn Life Sciences Investors (HQL) in Q2 2020, closing a stake of 26,500 shares — an estimated $397K sold.

Lido Advisors first reported a position in HQL in Q3 2019 and held it in 3 quarters. The position peaked at $462K in Q4 2019. 70 funds tracked by Wall St. Rank hold HQL as of Q2 2020.

  • Lido Advisors reported no remaining abrdn Life Sciences Investors position as of Q2 2020 after selling out during the quarter.
  • Lido Advisors sold 26,500 abrdn Life Sciences Investors shares in Q2 2020, an estimated $397K.
  • Lido Advisors first reported a position in abrdn Life Sciences Investors in Q3 2019 and held it in 3 quarters.
  • Lido Advisors's abrdn Life Sciences Investors position peaked at $462K in Q4 2019.
  • 70 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2020.

Based on Lido Advisors's 13F filing for Q2 2020, filed 12 Aug 2020.